Groupe Athena Inc (GATA) 0.1001 $GATA Groupe At
Post# of 273371

Groupe Athena, Inc. Reiterates Revenue Guidance Despite Currency Depreciation
ACCESSWIRE - Tue May 24, 7:15AM CDT
MUMBAI, INDIA / ACCESSWIRE / May 24, 2016 / Groupe Athena, Inc. (OTC: GATA) announced today that the company is confident of meeting its projected revenue projections of $75 million in line with projections. The company also stated that it has an estimated $35 million of outstanding orders to provide a solid revenue base to build on for the 2017 fiscal period.
Groupe Athena, Inc. Posts Strong 3rd Quarter Results
ACCESSWIRE - Mon Apr 11, 6:15AM CDT
MUMBAI, INDIA / ACCESSWIRE / April 11, 2016 / Groupe Athena, Inc. (Pinksheets: GATA) announced today revenues of $15,162,114 for the period ending March 31, 2016. Operating income before depreciation, amortization and taxes were $2,063,959 while net income increased an impressive 52.89% compared to the corresponding period in 2015, to $1,640,944.
Groupe Athena, Inc. Posts 2nd Quarter Results, Records 20% Growth in Operating Income
ACCESSWIRE - Mon Mar 28, 8:00AM CDT
MUMBAI, INDIA / ACCESSWIRE / March 28, 2016 / Groupe Athena, Inc. (Pinksheets GATA.PK) announced revenues of $21,652,865 for the period ending December 31, 2015, an increase of $2,647,436 over the same period in 2014. Operating income before Depreciation and Amortization was $3,422,866 and reflects a Research and Development charge of $376,542. Net income for the period was $2,532,884 or $.05 per share.
Groupe Athena, Inc. Announces Revenue Update
ACCESSWIRE - Wed Nov 11, 8:15AM CST
MUMBAI, INDIA / ACCESSWIRE / November 11, 2015 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA) announced on November 11, 2015 that based on the orders in hand, the company expects to achieve total revenues of $75 million in the current fiscal year.
Groupe Athena Required Due Diligence for Investors - Broad Street Alerts
ACCESSWIRE - Tue Nov 10, 7:51AM CST
NEW YORK, NY / ACCESSWIRE / November 10, 2015 / Groupe Athena Inc. (OTCBB: GATA) shares closed yesterday at $.14 down 6.67% following the release of first quarter financial results Trading volume was 35,000 shares, much higher than the daily average of about 400 shares.
Groupe Athena, Inc. Posts Strong 1st Quarter Results
ACCESSWIRE - Mon Nov 09, 8:16AM CST
MUMBAI, INDIA / ACCESSWIRE / November 9, 2015 / Groupe Athena, Inc. (PINKSHEETS: GATA) today announced revenues of $22,672,908 for the period ending September 30, 2015, which represents an increase of $2,490,946 over the same period in 2014. Gross income before depreciation, amortization and taxes was $1,485,704 and reflects a Research and Development charge of $2,116,729.
Groupe Athena, Inc. Releases Year End Financials, Posts Record Revenue
eTeligis - Mon Jul 20, 3:15PM CDT
MUMBAI, India, via ETELIGIS INC., 07/20/2015 - - Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), is very excited to post the results for their fiscal year ending June 30, 2015. Annual revenue for the period was $70,867,148 which is an increase of 9% over the previous fiscal year and represents another new benchmark for the company. EBITDA for the year was also strong at $8,185,170 and net after tax income for the period was $4,613,321 or $.10 per share.
Groupe Athena, Inc. Nominated for CFI.co Award
ACCESSWIRE - Fri Jun 12, 8:15AM CDT
MUMBAI, INDIA / ACCESSWIRE / June 12, 2015 / Groupe Athena, Inc. (PINKSHEETS: GATA) announced today that it is one of 3 companies nominated for the prestigious CFI.co award for best pharmaceutical consultancy company from India. The final award will be announced by end July, 2015.
Groupe Athena, Inc. Issues Update on Atorvastatin Calcium Project
ACCESSWIRE - Thu Feb 19, 7:16AM CST
MUMBAI, IN / ACCESSWIRE / February 19, 2015 / Groupe Athena, Inc. (OTC: GATA) (PINKSHEETS: GATA) announced today that the company has started Pharmacokinetic (PK) modeling as part of its preclinical studies in its continuing efforts to start production of Atorvastatin Calcium. Pharmacokinetic modeling is a mathematical technique for predicting the effect and efficacy of drug dosing over time. Broadly speaking, pharmacokinetic models describe how the body reacts to a drug in terms of absorption, distribution, metabolism, and excretion.
Groupe Athena, Inc. Posts 2nd Quarter Results
ACCESSWIRE - Wed Jan 21, 8:57AM CST
MUMBAI, INDIA / ACCESSWIRE / January 21, 2015 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $19,005,429 for the period ending December 31, 2014, an increase of $1,043,977 over the same period in 2013. Operating income before Depreciation and Amortization was $2,845,789 and reflects a Research and Development charge of $428,659. Net income for the period was $1,859,924 or $.04 per share.
Groupe Athena, Inc. Posts Strong 1st Quarter Results, Sees Progress Toward Transition To Manufacturing
eTeligis - Mon Nov 17, 8:00AM CST
MUMBAI, India, via ETELIGIS INC., 11/17/2014 - - Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $20,181,962 for the period ending September 30, 2014, which represents an increase of $1,419,373 over the same period in 2013. Gross income before depreciation, amortization and taxes was $1,423,850. Operating income before Depreciation and Amortization was $1,423,850 and reflects a Research and Development charge of $1,862,065.

